Manulife (Manufacturers Life Insurance)
ACOR

Manulife (Manufacturers Life Insurance)’s Acorda Therapeutics ACOR Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-183
Closed -$20K – 2962
2020
Q1 		$20K Buy
183
+68
+59% +$13.4K ﹤0.01% 2784
2019
Q4 		$28K Sell
115
-133
-54% -$33.6K ﹤0.01% 2857
2019
Q3 		$89K Hold
248
– – ﹤0.01% 2850
2019
Q2 		$228K Buy
248
+2
+0.8% +$2.46K ﹤0.01% 2558
2019
Q1 		$393K Buy
246
+21
+9% +$37.8K ﹤0.01% 2184
2018
Q4 		$420K Sell
225
-18
-7% -$39.2K ﹤0.01% 2066
2018
Q3 		$572K Sell
243
-31
-11% -$96K ﹤0.01% 2180
2018
Q2 		$942K Buy
274
+2
+0.7% +$6.12K ﹤0.01% 1924
2018
Q1 		$773K Sell
272
-5
-2% -$15K ﹤0.01% 2005
2017
Q4 		$713K Buy
277
+1
+0.4% +$2.84K ﹤0.01% 2078
2017
Q3 		$783K Sell
276
-5
-2% -$13.2K ﹤0.01% 1963
2017
Q2 		$664K Sell
281
-3
-1% -$5.94K ﹤0.01% 2078
2017
Q1 		$717K Buy
284
+33
+13% +$95K ﹤0.01% 1945
2016
Q4 		$566K Buy
251
+6
+2% +$14.3K ﹤0.01% 2027
2016
Q3 		$613K Buy
245
+2
+0.8% +$5.97K ﹤0.01% 1952
2016
Q2 		$744K Buy
243
+6
+3% +$19.5K ﹤0.01% 1788
2016
Q1 		$749K Buy
237
+4
+2% +$16.6K ﹤0.01% 1751
2015
Q4 		$1.2K Buy
233
+2
+0.9% +$8.74K ﹤0.01% 1542
2015
Q3 		$735 Buy
231
+7
+3% +$27.1K ﹤0.01% 1760
2015
Q2 		$896 Sell
224
-5
-2% -$19.3K ﹤0.01% 1750
2015
Q1 		$915 Buy
229
+9
+4% +$41.2K ﹤0.01% 1739
2014
Q4 		$1.08K Sell
220
-6
-3% -$25.7K ﹤0.01% 1539
2014
Q3 		$918 Buy
226
+5
+2% +$18.8K ﹤0.01% 1610
2014
Q2 		$893K Sell
221
-36
-14% -$147K ﹤0.01% 1655
2014
Q1 		$1.17K Sell
257
-1
-0.4% -$4.04K ﹤0.01% 1533
2013
Q4 		$903 Hold
258
– – ﹤0.01% 1668
2013
Q3 		$1.06K Sell
258
-8
-3% -$34.5K ﹤0.01% 1523
2013
Q2 		$1.05M Buy
+266
New +$1.1M ﹤0.01% 1446

Other funds holding ACOR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s ACOR Position: Q2 2020 in Review

Manulife (Manufacturers Life Insurance) sold out of Acorda Therapeutics (ACOR) in Q2 2020, closing a stake of 183 shares — an estimated $20K sold.

Manulife (Manufacturers Life Insurance) first reported a position in ACOR in Q2 2013 and held it in 28 quarters. The position peaked at $1.05M in Q2 2013. 79 funds tracked by Wall St. Rank hold ACOR as of Q2 2020.

  • Manulife (Manufacturers Life Insurance) reported no remaining Acorda Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 183 Acorda Therapeutics shares in Q2 2020, an estimated $20K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Acorda Therapeutics in Q2 2013 and held it in 28 quarters.
  • Manulife (Manufacturers Life Insurance)'s Acorda Therapeutics position peaked at $1.05M in Q2 2013.
  • 79 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2020.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2020, filed 10 Aug 2020.